Pharmacy Board warns against sale, import of unregistered products
Health & Science
By
Betty Njeru
| Jan 18, 2025
Government registered drugs found at a pharmacy in Kayole estate, Nairobi. [File, Standard]
The Pharmacy and Poisons Board (PPB) has issued a stern warning to health stakeholders against trading, importing, or handling unregistered pharmaceutical products in Kenya.
In a statement on Saturday, January 18, the PPB specifically cautioned against products referencing the Indian Pharmacopeia (IP).
“All stakeholders are hereby directed to cease and desist from trading, importing, or handling any unregistered products and ensure that all pharmaceutical products in their possession are duly registered and approved by the Pharmacy and Poisons Board,” the statement read.
The Board warned that noncompliance with this directive would result in the revocation of licenses and the seizure of products.
READ MORE
Directline insurance moves to repair image amid shareholder wrangles
New KRA boss Muriithi wants outdated annual Finance Bill scrapped
Kenya-UAE deal could be a catalyst for job creation and an economic booster
Survey reveals housing project has missed the mark, is doomed to fail
TikTok's US future in limbo after Supreme Court ruling
End of the road for CMC Motors as auto dealer to close shop
Prateek Suri: How the richest Indian billionaire in Africa is increasing ties through innovation
Kenya to host top African logistics event
The Indian Pharmacopeia is a set of standards for drugs and medicines manufactured, sold, and consumed in India.
However, the PPB clarified that these standards are not recognised under Kenya’s drug registration requirements, rendering products citing the IP non-compliant.
The Board further said it is actively monitoring the market and will take action against anyone found violating the regulatory framework.